Skip to main content
Fig. 4 | Breast Cancer Research

Fig. 4

From: Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes

Fig. 4

Breast cancer survival according to diabetes mellitus (DM) and metformin treatment (MET). (a) Overall survival. (b) Cancer-specific survival. (c) Disease-free survival. Adjusted for tumor size (≤2 versus > 2 cm), lymph node status (positive versus negative), estrogen receptor status, progesterone receptor status, human epidermal growth factor receptor-2 (HER2)-neu status (non-amplification versus amplification), chemotherapy and endocrine therapy

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us